waveLINE-007: Phase 2 study of zilovertamab vedotin (ZV) in combination with cyclophosphamide, doxorubicin, and prednisone plus rituximab (R-CHP) in previously untreated diffuse large B-cell lymphoma (DLBCL).
JOURNAL OF CLINICAL ONCOLOGY, cilt.41, sa.16, 2023 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Özet
- Cilt numarası: 41 Sayı: 16
- Basım Tarihi: 2023
- Dergi Adı: JOURNAL OF CLINICAL ONCOLOGY
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, PASCAL, CAB Abstracts, CINAHL, Gender Studies Database, International Pharmaceutical Abstracts, Veterinary Science Database
- Ankara Üniversitesi Adresli: Evet